The mechanism of blood brain barrier impairment in cerebral cavernous malformatio

脑海绵状血管瘤血脑屏障损伤的机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Cerebral cavernous malformations (CCMs) are the most common brain vascular malformations and are detected in the population at a rate of approximately 0.6 per 100,000. Recognized as familial or sporadic cases, CCMs are characterized as single of multi cluster of enlarged capillary-like channels with a single layer of endothelium and without intervening brain parenchyma. There are specific alterations in brain endothelial barrier components that ultimately lead to vascular hyperpermeability, extravasation of red cells and inflammatory response in brain parenchyma. Patients with CCMs may present with seizures, focal deficits, or nonspecific headaches and as most common complication is hemorrhagic stroke. Although significant effort has been made in defining the genes mutations involved in inherited CCMs, the intra- and intercellular pathogenic mechanisms responsible for vascular hyperpermeability are still largely unknown. The proposed study is designed to elucidate critical molecular events in maintaining the integrity of the brain endothelial barrier and how these are altered cerebral cavernous malformation type 3. In particular, the proposal will address the multisequential events involved in organization of the TJ complex. It will highlight how the interaction between signaling molecules, CCM3 protein and an actin cytoskeleton protein, cortactin, affect the organization and stability of brain endothelial tight junctional complex. Specifically, the following objectives will be evaluated: a) the functional and morphological consequence of CCM3 absence on TJ complex/actin cytoskeleton interactions in conditions of CCM3 pathology and b) the role of CCM3-cortactin interaction in establishing stable interactions between ZO-1 and the actin cytoskeleton and ZO-1 and claudin-5. Collectively, these studies will provide new information related to the mechanisms involved in maintaining the brain endothelial barrier that is relevant not only to CCM3 but also to multiple disease states. Hopefully, this will help to elucidate novel therapeutic strategies to restore vascular hyperpermeability.
描述(申请人提供):脑海绵状血管畸形(CCM)是最常见的脑血管畸形,在人群中以大约每10万人中0.6人的比率被发现。CCM被认为是家族性或散发性病例,其特点是单个或多个增大的毛细血管样通道,内皮细胞单层,不干预脑实质。脑内皮细胞屏障成分有特定的变化,最终导致血管高通透性、红细胞外溢和脑实质的炎症反应。CCM患者可能会出现癫痫发作、局灶性缺陷或非特异性头痛,最常见的并发症是出血性中风。尽管在确定遗传性CCM涉及的基因突变方面已经做出了重大努力,但导致血管高通透性的细胞内和细胞间的致病机制仍然很大程度上是未知的。这项拟议的研究旨在阐明维持脑内皮细胞屏障完整性的关键分子事件以及这些事件是如何改变脑3型海绵状畸形的。特别是,该研究将解决参与TJ复合体组织的多序列事件。它将强调信号分子CCM3蛋白和肌动蛋白细胞骨架蛋白Cortactin之间的相互作用如何影响脑内皮紧密连接复合体的组织和稳定性。具体来说,将评估以下目标:a)在CCM3病理条件下,CCM3缺失对TJ复合体/肌动蛋白细胞骨架相互作用的功能和形态影响,以及b)CCM3-Cortactin相互作用在建立ZO-1和肌动蛋白细胞骨架与ZO-1和claudin-5之间稳定相互作用中的作用。总的来说,这些研究将提供与维持脑内皮屏障的机制有关的新信息,这不仅与CCM3有关,而且与多种疾病状态有关。希望这将有助于阐明恢复血管高通透性的新治疗策略。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.
  • DOI:
    10.1007/s00401-015-1479-z
  • 发表时间:
    2015-11
  • 期刊:
  • 影响因子:
    12.7
  • 作者:
    Stamatovic SM;Sladojevic N;Keep RF;Andjelkovic AV
  • 通讯作者:
    Andjelkovic AV
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANUSKA V. ANDJELKOVIC-ZOCHOWSKA其他文献

ANUSKA V. ANDJELKOVIC-ZOCHOWSKA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANUSKA V. ANDJELKOVIC-ZOCHOWSKA', 18)}}的其他基金

Deciphering the role of junctional adhesion molecule-A in neutrophil-driven inflammatory response in Alzheimer disease
解读连接粘附分子-A 在阿尔茨海默病中性粒细胞驱动的炎症反应中的作用
  • 批准号:
    10752753
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Molecular mechanism mediating apicobasal brain endothelial cells polarity in cerebral cavernous malformation type 3-lesion
脑海绵状血管瘤3型病变中顶基底层脑内皮细胞极性的分子机制
  • 批准号:
    10526456
  • 财政年份:
    2022
  • 资助金额:
    $ 19.44万
  • 项目类别:
The mechanism of blood brain barrier impairment in cerebral cavernous malformatio
脑海绵状血管瘤血脑屏障损伤的机制
  • 批准号:
    8166264
  • 财政年份:
    2011
  • 资助金额:
    $ 19.44万
  • 项目类别:
The blood brain barrier in neuroinflammation
神经炎症中的血脑屏障
  • 批准号:
    7781058
  • 财政年份:
    2009
  • 资助金额:
    $ 19.44万
  • 项目类别:
Effect of nicotine on postischemic brain inflammation.
尼古丁对缺血后脑炎症的影响。
  • 批准号:
    7587078
  • 财政年份:
    2008
  • 资助金额:
    $ 19.44万
  • 项目类别:
Blood-Brain Barrier in Neuroinflammation
神经炎症中的血脑屏障
  • 批准号:
    8550172
  • 财政年份:
    2008
  • 资助金额:
    $ 19.44万
  • 项目类别:
Chemokine Effects on Blood-brain Barrier Permeability
趋化因子对血脑屏障通透性的影响
  • 批准号:
    6720934
  • 财政年份:
    2003
  • 资助金额:
    $ 19.44万
  • 项目类别:
Chemokine Effects on Blood-brain Barrier Permeability
趋化因子对血脑屏障通透性的影响
  • 批准号:
    6982792
  • 财政年份:
    2003
  • 资助金额:
    $ 19.44万
  • 项目类别:
Chemokine Effects on Blood-brain Barrier Permeability
趋化因子对血脑屏障通透性的影响
  • 批准号:
    6823224
  • 财政年份:
    2003
  • 资助金额:
    $ 19.44万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了